Vega Investment Solutions Purchases Shares of 10,432 Agilent Technologies, Inc. $A

Vega Investment Solutions purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 10,432 shares of the medical research company’s stock, valued at approximately $1,386,000.

A number of other large investors also recently modified their holdings of the business. Norges Bank acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $549,158,000. Bank of New York Mellon Corp boosted its position in Agilent Technologies by 87.4% during the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after purchasing an additional 2,440,360 shares during the last quarter. AQR Capital Management LLC boosted its position in Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares during the last quarter. Ameriprise Financial Inc. grew its stake in Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Finally, Findlay Park Partners LLP bought a new position in Agilent Technologies in the second quarter valued at approximately $174,281,000.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on A. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price objective for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a research note on Friday, June 26th. They issued an “outperform” rating and a $155.00 target price for the company. Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Barclays upped their price target on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Finally, Royal Bank Of Canada started coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target for the company. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Stock Performance

A opened at $153.37 on Tuesday. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.51. The stock has a market cap of $43.32 billion, a price-to-earnings ratio of 30.80, a PEG ratio of 2.80 and a beta of 1.25. The business has a 50 day moving average of $138.03 and a 200-day moving average of $126.32. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities research analysts expect that Agilent Technologies, Inc. will post 6.05 earnings per share for the current year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.